Published September 12, 2013 | Version v1
Patent Open

NK-1 Receptor Mediated Delivery of Agents to Cells

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Provided herein are conjugates including a targeting vehicle coupled to an agent. The targeting vehicle includes a tachykinin receptor ligand and a reactive moiety. Conjugates including a tachykinin receptor ligand attached to an antibody or fragment thereof that is specific for an intracellular target are also provided. Also provided are methods of delivering agents to cells expressing tachykinin receptors, methods of delivering antibodies or fragments thereof to an intracellular extra-endosomal target, and methods of arresting cell growth or introducing cell death of a cancer cell.

Files

US20130236966.pdf

Files (869.5 kB)

Name Size Download all
md5:10d56c00e243c2754b2975669ff98c7c
869.5 kB Preview Download

Additional details

Identifiers

Patent number
US 201213714780 A
Patent application number
US 2013/0236966 A1
Other
oai:uchicago.tind.io:9014

Dates

Patent filed
2012-12-14

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Biochemistry and Molecular Biology